Die Hemmkörper-Hämophilien. Risikofaktoren und Therapieoptionen
- 1 January 2006
- journal article
- review article
- Published by Wiley in Pharmazie in unserer Zeit
- Vol. 35 (1) , 58-64
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Prophylactic treatment effects on inhibitor risk: experience in one centreHaemophilia, 2005
- Treatment of patients with acquired inhibitorsJournal of Thrombosis and Haemostasis, 2005
- Environmental and genetic factors influencing inhibitor developmentSeminars in Hematology, 2004
- The epidemiology of inhibitors in haemophilia A: a systematic reviewHaemophilia, 2003
- Control of bleeding in patients with haemophilia A with inhibitors: a systematic reviewHaemophilia, 2003
- Acquired Haemophilia: Review and Meta‐Analysis Focused on Therapy and Prognostic FactorsBritish Journal of Haematology, 2003
- Molecular Biology of Blood CoagulationSeminars in Thrombosis and Hemostasis, 2001
- Definitions in HemophiliaThrombosis and Haemostasis, 2001
- Incidence of development of factor VIII and factor IX inhibitors in haemophiliacsThe Lancet, 1992
- Factor VIII InhibitorsAnnals of the New York Academy of Sciences, 1987